Chemoinformaics analysis of 3-ETHENYL-2,5-DIMETHYLHEXA-1,4-DIENE
| Molecular Weight | 136.238 | nRot | 3 |
| Heavy Atom Molecular Weight | 120.11 | nRig | 16 |
| Exact Molecular Weight | 136.125 | nRing | 0 |
| Solubility: LogS | -2.032 | nHRing | 0 |
| Solubility: LogP | 1.024 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 27.3687 |
| nHD | 0 | BPOL | 16.0513 |
| QED | 0.635 |
| Synth | 2.281 |
| Natural Product Likeliness | 0.55 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.002 |
| CACO-2 | -4.564 |
| MDCK | 0.0000238 |
| BBB | 0.982 |
| PPB | 0.599886 |
| VDSS | 1.808 |
| FU | 0.39898 |
| CYP1A2-inh | 0.949 |
| CYP1A2-sub | 0.731 |
| CYP2c19-inh | 0.423 |
| CYP2c19-sub | 0.79 |
| CYP2c9-inh | 0.037 |
| CYP2c9-sub | 0.808 |
| CYP2d6-inh | 0.775 |
| CYP2d6-sub | 0.871 |
| CYP3a4-inh | 0.552 |
| CYP3a4-sub | 0.217 |
| CL | 7.076 |
| T12 | 0.697 |
| hERG | 0.029 |
| Ames | 0.02 |
| ROA | 0.015 |
| SkinSen | 0.147 |
| Carcinogencity | 0.955 |
| EI | 0.249 |
| Respiratory | 0.032 |
| NR-Aromatase | 0.03 |
| Antiviral | No |
| Prediction | 0.945956 |